VI
KNSA icon

Vestcor Inc’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Vestcor Inc’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$839K Buy
13,123
+7,500
+133% +$389K 0.02% 619
2026
Q1 		$271K Hold
5,623
– – 0.01% 954
2025
Q4 		$232K Hold
5,623
– – 0.01% 929
2025
Q3 		$218K Buy
+5,623
New +$183K 0.01% 961
2024
Q2 		– Sell
-17,000
Closed -$335K – 1218
2024
Q1 		$335K Sell
17,000
-17,434
-51% -$340K 0.01% 793
2023
Q4 		$604K Hold
34,434
– – 0.02% 598
2023
Q3 		$598K Hold
34,434
– – 0.02% 562
2023
Q2 		$485K Buy
34,434
+8,539
+33% +$114K 0.02% 613
2023
Q1 		$279K Buy
+25,895
New +$341K 0.01% 787

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Vestcor Inc's KNSA Position: Q2 2026 in Review

Vestcor Inc increased its Kiniksa Pharmaceuticals (KNSA) stake by 133% in Q2 2026, buying an estimated $389K and bringing the position to 13,123 shares worth $839K. The position accounts for 0.02% of the portfolio, ranked #619.

Vestcor Inc first reported a position in KNSA in Q1 2023 and has held it in 9 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Vestcor Inc held 13,123 shares of Kiniksa Pharmaceuticals worth $839K as of Q2 2026.
  • Vestcor Inc bought 7,500 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $389K.
  • Kiniksa Pharmaceuticals made up 0.02% of Vestcor Inc's portfolio in Q2 2026, its #619 holding.
  • Vestcor Inc first reported a position in Kiniksa Pharmaceuticals in Q1 2023 and has held it in 9 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.